United States Cardiac Marker Test Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Cardiac Marker Test Markets, Executive SummaryIntroduction to the Cardiac Marker MarketIntroduction to the Cardiac Marker MarketReport Scope and SegmentationReport StructureSummary of Major FindingsMarket Growth, Opportunities, and Total ForecastTotal Revenues and Revenue Growth RatesPercent of Revenues by Product TypeAnalysis by Major SegmentCompetitive AnalysisTechnology TrendsConclusionsUnited States Cardiac Marker Test Markets, Market Engineering Research MethodologyFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryResearch SourcesSecondary SourcesPrimary ResearchClinical Diagnostic Forecast ModelClinical Diagnostic Forecast ModelProduct-Based ForecastPopulation-Based ForecastEnd User-Based ForecastMarket Model AssumptionsResearch LimitationsPresentation of Market Engineering Measurements, Definition and their Strategic SignificancePresentation of Market Engineering Measurements, Definition and their Strategic SignificanceGlossaryList of DefinitionsList of AcronymsUnited States Cardiac Marker Test Markets, Challenges and Opportunities in the Cardiac Marker MarketIdentification of Challenges Facing the Cardiac Marker MarketIdentification of Challenges Facing the Cardiac Marker MarketAccelerating Mergers Shift Supply Side, Creating Difficulty for Smaller CompetitorsLack of Guidelines or Protocols Stalls Effective Use of Cardiac MarkersManaged Care Environment Requires Manufacturers to Highlight Cost Benefit AnalysisTechnological Advances in Therapy Mandates Improved Diagnostic SettingsLitigation over Missed Diagnosis Offers Challenge for Better AMI ManagementMaximizing the Impact of the Tests Requires Publicizing for Effective UseLengthy Regulatory Process Adversely Effects Business OperationsStandardization of Tests Needed to Increase Confidence Limit of Cardiac TestsIntensely Competitive Industry Squeezing ProfitsIntroduction of Point-of-Care Tests Requires Regulatory GuidelinesIdentification of Opportunities Presented in the Cardiac Marker Test MarketIdentification of Opportunities Presented in the Cardiac Marker Test MarketEmergence of Chest Pain Units Provides Opportunity to Vendors to Develop Responsive Technologies and SystemsNeed for Rapid Cardiac Bedside Tests Provides Break for Manufacturers in the Point-of-Care MarketDefinitive Diagnosis of AMI for Patients Receiving Thrombolytic Therapy Opens Avenues for New Specific TestsGuidelines Pave Way for New TestsBetter AMI Management Creates Opening Niche Market ParticipantsLaboratories Need for STAT Tests Extends Innovative ProcessCustomers Desire to Avoid Risks Associated with Technological Obsolescence Gives Way to Leasing ProgramsChanges in the Healthcare Industry Creates Unobstructed Path for Amalgamation of CompaniesDemand for Flexibility in Work Flow of the Laboratories Provides Opportunities for Alternate ApproachMarket Engineering Research for the Cardiac Marker Laboratory-Based Test Market 1995-2005Total Market AnalysisMarket Overview and DefinitionsDisease OverviewMarket DriversMarket RestraintsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market and Technology TrendsCompetitive StructureCompetitive AnalysisProduct AnalysisStrategic Analysis and Forecasts of the Cardiac Troponin (I & T) MarketMarket Overview and DefinitionsMarket DriversMarket RestraintsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market and Technology TrendsCompetitive StructureProduct AnalysisStrategic Analysis and Forecasts of the Cardiac Myoglobin MarketMarket Overview and DefinitionsMarket DriversMarket RestraintsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market and Technology TrendsCompetitive StructureProduct AnalysisStrategic Analysis and Forecasts of the Cardiac CK-MB MarketMarket Overview and DefinitionsMarket DriversMarket RestraintsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market and Technology TrendsCompetitive AnalysisProduct AnalysisMarket Engineering Research for the Cardiac Marker Rapid Assay Market 1995-2005Total Market AnalysisMarket Overview and DefinitionsMarket DriversMarket RestraintsMarket IssuesMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market and Technology TrendsPricing Strategy and Trend AnalysisCompetitive StructureUnited States Cardiac Marker Test Markets, Market Engineering StrategyMeasurements That Address Challenges to the IndustryMeasurements That Address Challenges to the IndustryMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsMarketing DepartmentResearch and Development Department




Related Research

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 15-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.